Europe Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Report Coverage:
  • Type (Embolization Coils, Plugs, Beads, Glues, Others)
  • Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, Others)
  • End User (Hospitals, Ambulatory Centers, Others)

No. of Pages: 194
Report Code: BMIRE00032147
Category: Life Sciences
Europe Embolization Devices Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Embolization Devices Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Embolization Devices Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Embolization Devices Market Regional Analysis

6.2 Europe Embolization Devices Market Revenue 2021-2031 (US$ Million)
6.3 Europe Embolization Devices Market Forecast Analysis

7. Europe Embolization Devices Market Analysis – by Type

7.1 Embolization Coils
  • 7.1.1 Overview
  • 7.1.2 Embolization Coils: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Plugs
  • 7.2.1 Overview
  • 7.2.2 Plugs: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Beads
  • 7.3.1 Overview
  • 7.3.2 Beads: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Glues
  • 7.4.1 Overview
  • 7.4.2 Glues: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Embolization Devices Market Analysis – by Application

8.1 Neurology
  • 8.1.1 Overview
  • 8.1.2 Neurology: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Peripheral Vascular Disease
  • 8.2.1 Overview
  • 8.2.2 Peripheral Vascular Disease: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Oncology
  • 8.3.1 Overview
  • 8.3.2 Oncology: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Urology
  • 8.4.1 Overview
  • 8.4.2 Urology: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Embolization Devices Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Ambulatory Centers
  • 9.2.1 Overview
  • 9.2.2 Ambulatory Centers: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others: Europe Embolization Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Embolization Devices Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Embolization Devices Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 Europe Embolization Devices Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 UK: Europe Embolization Devices Market Breakdown, by Type
    • 10.2.1.1.2 UK: Europe Embolization Devices Market Breakdown, by Application
    • 10.2.1.1.3 UK: Europe Embolization Devices Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Embolization Devices Market Breakdown, by Type
    • 10.2.1.2.2 Germany: Europe Embolization Devices Market Breakdown, by Application
    • 10.2.1.2.3 Germany: Europe Embolization Devices Market Breakdown, by End User
  • 10.2.1.3 France: Europe Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 France: Europe Embolization Devices Market Breakdown, by Type
    • 10.2.1.3.2 France: Europe Embolization Devices Market Breakdown, by Application
    • 10.2.1.3.3 France: Europe Embolization Devices Market Breakdown, by End User
  • 10.2.1.4 Spain: Europe Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.4.1 Spain: Europe Embolization Devices Market Breakdown, by Type
    • 10.2.1.4.2 Spain: Europe Embolization Devices Market Breakdown, by Application
    • 10.2.1.4.3 Spain: Europe Embolization Devices Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Embolization Devices Market Breakdown, by Type
    • 10.2.1.5.2 Italy: Europe Embolization Devices Market Breakdown, by Application
    • 10.2.1.5.3 Italy: Europe Embolization Devices Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Embolization Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Embolization Devices Market Breakdown, by Type
    • 10.2.1.6.2 Rest of Europe: Europe Embolization Devices Market Breakdown, by Application
    • 10.2.1.6.3 Rest of Europe: Europe Embolization Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Medtronic Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Cook Medical Holdings LLC
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Stryker Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Boston Scientific Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Terumo Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Johnson & Johnson
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Abbott Laboratories
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 NeuroSafe Medical Co. Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Wallaby Medical
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Sirtex Medical Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 GEM srl
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Penumbra Inc.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Balt
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 Lepu Medical Technology Beijing Co Ltd
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 INVAMED
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments
13.16 Meril Life Sciences Pvt Ltd
  • 13.16.1 Key Facts
  • 13.16.2 Business Description
  • 13.16.3 Products and Services
  • 13.16.4 Financial Overview
  • 13.16.5 SWOT Analysis
  • 13.16.6 Key Developments
13.17 Merit Medical Systems Inc
  • 13.17.1 Key Facts
  • 13.17.2 Business Description
  • 13.17.3 Products and Services
  • 13.17.4 Financial Overview
  • 13.17.5 SWOT Analysis
  • 13.17.6 Key Developments
13.18 Lifetech Scientific Corp
  • 13.18.1 Key Facts
  • 13.18.2 Business Description
  • 13.18.3 Products and Services
  • 13.18.4 Financial Overview
  • 13.18.5 SWOT Analysis
  • 13.18.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Embolization Devices Market

  • Medtronic Plc
  • Cook Medical Holdings LLC
  • Stryker Corp
  • Boston Scientific Corp
  • Terumo Corp
  • Johnson & Johnson
  • Abbott Laboratories
  • NeuroSafe Medical Co. Ltd
  • Wallaby Medical
  • Sirtex Medical Ltd
  • GEM srl
  • Penumbra Inc.
  • Balt
  • Lepu Medical Technology Beijing Co Ltd
  • INVAMED
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Lifetech Scientific Corp
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)